A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Public ClinicalTrials.gov record NCT07415954. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Efficacy and Safety of Once-weekly Subcutaneous NNC0662-0419 in Participants With Type 2 Diabetes - a Dose-finding Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is being done to look at the effect and safety of different doses of NNC0662-0419 in people living with type 2 diabetes when compared to placebo or semaglutide. The purpose of this clinical study is to find out if NNC0662-0419 is effective and safe for treating people living with type 2 diabetes. Participants will get either NNC0662-0419, semaglutide or placebo. Which treatment participants get is decided by chance. NNC0662-0419 is a new medicine which cannot be prescribed by doctors but has previously been tested in humans. Semaglutide is an approved medication to treat type 2 diabetes.
Study identification
- NCT ID
- NCT07415954
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 270 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 16, 2026
- Primary completion
- Sep 2, 2027
- Completion
- Sep 30, 2027
- Last update posted
- Aug 9, 2026
2026 – 2027
United States locations
- U.S. sites
- 23
- U.S. states
- 11
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| First Valley Medical Group | Lancaster | California | 93534 | Recruiting |
| Torrance Clinical Research Institute, Inc. | Lomita | California | 90717 | Recruiting |
| Ark Clinical Research | Long Beach | California | 90815 | Recruiting |
| Pacific Clinical Studies | Los Alamitos | California | 90720 | Recruiting |
| Wetlin Research Associates, Inc. | San Diego | California | 92120 | Recruiting |
| Diablo Clinical Research, Inc. | Walnut Creek | California | 94598 | Recruiting |
| Encore Medical Research LLC | Hollywood | Florida | 33024 | Recruiting |
| Bioclinical Research Alliance | Miami | Florida | 33155 | Recruiting |
| South Broward Research LLC | Miramar | Florida | 33027 | Recruiting |
| West Orange Endocrinology | Ocoee | Florida | 34761 | Not yet recruiting |
| Encore Medical Research of Weston | Weston | Florida | 33331 | Recruiting |
| Elite Clinical Trials | Blackfoot | Idaho | 83221 | Recruiting |
| Cedar-Crosse Research Center | Chicago | Illinois | 60607 | Recruiting |
| Brigham & Women's Hospital | Boston | Massachusetts | 02115-5804 | Not yet recruiting |
| Headlands Research | Springfield | Missouri | 65807 | Recruiting |
| PharmQuest | Greensboro | North Carolina | 27408 | Recruiting |
| Piedmont Healthcare Statesville | Statesville | North Carolina | 28625 | Recruiting |
| Providence Center for Clinical Research | Dayton | Ohio | 45439 | Recruiting |
| CNS Healthcare | Memphis | Tennessee | 38119 | Recruiting |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390-9302 | Recruiting |
| JCCT- Juno NW Houston | Houston | Texas | 77040 | Recruiting |
| Consano Clinical Research, LLC | Shavano Park | Texas | 78231 | Recruiting |
| Frontier Clinical Research - Kingwood | Kingwood | West Virginia | 26537 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07415954, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 9, 2026 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07415954 live on ClinicalTrials.gov.